Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple Assays.

Neal F, Arnold J, Rossant CJ, Podichetty S, Lowne D, Dobson C, Wilkinson T, Colley C, Howes R, Vaughan TJ.

J Biomol Screen. 2016 Jan;21(1):24-34. doi: 10.1177/1087057115610070. Epub 2015 Oct 8.

PMID:
26450103
2.

Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.

Rossant CJ, Carroll D, Huang L, Elvin J, Neal F, Walker E, Benschop JJ, Kim EE, Barry ST, Vaughan TJ.

MAbs. 2014;6(6):1425-38. doi: 10.4161/mabs.34376.

3.

Application of the mirrorball high-sensitivity cytometer to multiplexed assays for antibody drug discovery.

England E, Newton P, Neal F, Kitching L, Colley C, Rossant CJ.

J Biomol Screen. 2015 Apr;20(4):536-44. doi: 10.1177/1087057114557776. Epub 2014 Nov 7.

PMID:
25381256
4.

Versatility of homogeneous time-resolved fluorescence resonance energy transfer assays for biologics drug discovery.

Rossant CJ, Matthews C, Neal F, Colley C, Gardener MJ, Vaughan T.

J Biomol Screen. 2015 Apr;20(4):508-18. doi: 10.1177/1087057114557464. Epub 2014 Nov 7.

PMID:
25381254
5.

Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.

Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, James MA, Knight J, Markus HS, Mistri AK, Poulter NR; COSSACS Investigators.

Lancet Neurol. 2010 Aug;9(8):767-75. doi: 10.1016/S1474-4422(10)70163-0.

PMID:
20621562
6.

The foundations of the Irish settlement in Newcastle upon Tyne: the evidence in the 1851 census.

Neal F.

Immigr Minor. 1999;18(2-3):71-93. doi: 10.1080/02619288.1999.9974969. No abstract available.

PMID:
21391367
7.

Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study.

Kaldor JM, Day NE, Kittelmann B, Pettersson F, Langmark F, Pedersen D, Prior P, Neal F, Karjalainen S, Bell J, et al.

Int J Cancer. 1995 Sep 27;63(1):1-6.

PMID:
7558434
8.

Gestational trophoblastic disease - experience of the sheffield (United-kingdom) supraregional screening and treatment service.

Sheridan E, Hancock B, Smith S, Dorreen M, Neal F, Pennington G, Millar D.

Int J Oncol. 1993 Aug;3(2):149-55.

PMID:
21573340
9.

Undergraduate medical teaching in departments of oncology in the United Kingdom: a questionnaire survey.

Ramakrishnan S, Bolger JJ, Dunn KS, Neal FE, Hancock BW.

J Cancer Educ. 1993 Spring;8(1):25-30.

PMID:
8489906
10.

Radiation dose and breast cancer risk in patients treated for cancer of the cervix.

Boice JD Jr, Blettner M, Kleinerman RA, Engholm G, Stovall M, Lisco H, Austin DF, Bosch A, Harlan L, Krementz ET, Latouret HB, Merril JA, Petters LJ, Schulz MD, Wactawski J, Storm HH, Björkholm E, Pettersson F, Bell CM, Coleman MP, Fraser P, Neal FE, Prior P, Choi NW, Hislop TG, Koch M, Kreiger N, Robb D, Robson D, Thomson DH, Lochmüller H, von Fournier D, Frischkorn R, Kjørstad KE, Rimpela A, Pejovic MH, Kirn VP, Stankusova H, Pisani P, Sigurdsson K, Hutchison GB, MacMahon B.

Int J Cancer. 1989 Jul 15;44(1):7-16. Erratum in: Int J Cancer 1991 Jul;127(1):118.

PMID:
2744900
11.

Radiation dose and second cancer risk in patients treated for cancer of the cervix.

Boice JD Jr, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, Moloney WC, Austin DF, Bosch A, Cookfair DL, Krementz ET, Latourette HB, Merrill JA, Peters LJ, Schulz MD, Storm HH, Bjorkholm E, Pettersson F, Janine Bell CM, Coleman MP, Fraser P, Neal FE, Prior P, Choi NW, Hislop TG, Koch M, Kreiger N, Robb D, Robson D, Thomson DH, Lochmuller H, von Fournier D, Frischkorn R, Kjørstad KE, Rimpela A, Pejovic MH, Kirn VP, Stankusova H, Berrino F, Sigurdsson K, Hutchison GB, MacMahon B.

Radiat Res. 1988 Oct;116(1):3-55.

PMID:
3186929
12.

Results of low-dose methotrexate treatment of persistent gestational trophoblastic disease in Sheffield 1980-1987.

Dorreen MS, Pennington GW, Millar DR, Hill AS, Neal FE.

Acta Oncol. 1988;27(5):551-6.

PMID:
2849467
13.

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

Kaldor JM, Day NE, Band P, Choi NW, Clarke EA, Coleman MP, Hakama M, Koch M, Langmark F, Neal FE, et al.

Int J Cancer. 1987 May 15;39(5):571-85.

PMID:
3570550
14.

Mechanism of malignant hypercalcaemia in carcinoma of the breast.

Percival RC, Yates AJ, Gray RE, Galloway J, Rogers K, Neal FE, Kanis JA.

Br Med J (Clin Res Ed). 1985 Sep 21;291(6498):776-9.

15.

Treatment of malignant hypercalcaemia with clodronate.

Percival RC, Paterson AD, Yates AJ, Beard DJ, Douglas DL, Neal FE, Russell RG, Kanis JA.

Br J Cancer. 1985 May;51(5):665-9.

16.

Role of glucocorticoids in management of malignant hypercalcaemia.

Percival RC, Yates AJ, Gray RE, Neal FE, Forrest AR, Kanis JA.

Br Med J (Clin Res Ed). 1984 Aug 4;289(6440):287. No abstract available.

17.

Cases of carcinoma of thyroid following iodine-131 therapy for hyperthyroidism.

Gossage AA, Neal FE, Ross CM, Talbot CH, Blake GM, Munro DS.

Oncology. 1984;41(1):8-12. No abstract available.

PMID:
6700935
18.

Morphologic alteration of Anaplasma marginale in calves treated with a dithiosemicarbazone.

Simpson CF, Neal FC.

Am J Vet Res. 1982 Nov;43(11):1903-6.

PMID:
7181188
19.

Experimental Naegleria fowleri meningoencephalitis in sheep: light and electron microscopic studies.

Simpson CF, Willaert E, Neal FC, Stevens AR, Young MD.

Am J Vet Res. 1982 Jan;43(1):154-7.

PMID:
7091810
20.

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Wilson AP, Neal FE.

Br J Cancer. 1981 Aug;44(2):189-200.

Supplemental Content

Loading ...
Support Center